3 High-Yield Dividend Growth Stocks to Buy in December and Hold for a Decade or LongerThe Motley Fool • 12/03/24
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +Seeking Alpha • 11/16/24
3 High-Yield Dividend Stocks You Can Buy With $130 Now and Hold at Least a DecadeThe Motley Fool • 11/14/24
Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 MillionGlobeNewsWire • 11/07/24
Compared to Estimates, Royalty Pharma (RPRX) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/06/24
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for NiktimvoGlobeNewsWire • 11/04/24
Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™PRNewsWire • 11/04/24
Unveiling Royalty Pharma (RPRX) Q3 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 11/01/24
Royalty Pharma (RPRX) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 10/30/24
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024GlobeNewsWire • 10/16/24
3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a DecadeThe Motley Fool • 09/16/24
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding AgreementGlobeNewsWire • 09/03/24
Royalty Pharma to Present at Morgan Stanley's 22nd Annual Global Healthcare ConferenceGlobeNewsWire • 08/28/24